Familial aggregation of juvenile idiopathic arthritis with other autoimmune diseases: Impact on clinical characteristics, disease activity status and disease damage

Objectives To evaluate the impact of family history of autoimmune diseases (FHADs) on the clinical characteristics and outcome of juvenile idiopathic arthritis (JIA). Methods We retrospectively reviewed children with JIA seen in 7 pediatric rheumatology clinics from 6 Arab countries. All included pa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of rheumatic diseases 2021-08, Vol.24 (8), p.1080-1085
Hauptverfasser: Al‐Mayouf, Sulaiman M., Alrasheedi, Abeer, Almsellati, Iman, Hashad, Soad, Khawaja, Khulood, Abdwani, Reem, AlHashim, Samia, Muzaffer, Mohammed, Lotfy, Hala, Almutairi, Nora
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1085
container_issue 8
container_start_page 1080
container_title International journal of rheumatic diseases
container_volume 24
creator Al‐Mayouf, Sulaiman M.
Alrasheedi, Abeer
Almsellati, Iman
Hashad, Soad
Khawaja, Khulood
Abdwani, Reem
AlHashim, Samia
Muzaffer, Mohammed
Lotfy, Hala
Almutairi, Nora
description Objectives To evaluate the impact of family history of autoimmune diseases (FHADs) on the clinical characteristics and outcome of juvenile idiopathic arthritis (JIA). Methods We retrospectively reviewed children with JIA seen in 7 pediatric rheumatology clinics from 6 Arab countries. All included patients met the International League of Associations for Rheumatology classification criteria for JIA and had a disease duration greater than 1 year. Data were collected at the last follow‐up visit and comprised clinical findings, including FHADs. Disease activity and disease damage were assessed by Juvenile Arthritis Multidimensional Assessment Report, and juvenile arthritis damage index (JADI) respectively. Disease activity was categorized as remission off treatment, remission on treatment, or active disease. Results A total of 349 (224 females) JIA patients with a disease duration of 5 (interquartile range 2.9‐7.5) years were included. The most frequent JIA categories were polyarticular JIA and oligoarticular JIA, followed by systemic JIA. There were 189 patients with FHADs and 160 patients without FHADs. The most frequent FHADs were diabetes mellitus (21.2%), JIA (18.5%), rheumatoid arthritis (12.7%). Among patients with FHADs, 140/189 (74.1%) achieved clinical remission, while 131/160 (81.9%) patients without FHDs had clinical remission (odds ratio [OR] = 1.2, 95% CI 0.97‐1.5). Rate of consanguinity, enthesitis‐related arthritis (ERA) and psoriatic arthritis were higher in patients with FHADs (OR = 0.6, 95% CI 0.4‐0.9 and OR = 1.2, 95% CI 1.1‐1.4). Also, articular JADI correlated significantly with presence of FHADs (OR = 1.1, 95% CI 1.0‐1.1). Conclusion This study shows that autoimmune diseases cluster within families of patients with JIA with a high proportion of ERA and psoriatic arthritis. JIA patients with FHADs are likely to have more disease damage.
doi_str_mv 10.1111/1756-185X.14167
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2546597629</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2546597629</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3717-9dbaf65ecd9ff612e3573350da2b0d889b51898be11bf371d409c0e8423fb1593</originalsourceid><addsrcrecordid>eNqFkU1r3DAQhkVpaNK0596KoJccuolkW7LdWwhNE1hIDi30JsbSeD2LP7aSnLD_pz-02m6yh1yii8SrZ14GHsY-SXEu07mQpdILWanf57KQunzDTg7J28O7kMfsfQhrIbTMdfmOHedFSqtMnLC_1zBQT9BzWK08riDSNPKp5ev5AUfqkZOjaQOxI8vBx85TpMAfKXZ8ih16DnOcaBjmEbmjgBAwfOO3wwZs5KnK9jSSTf22A58y9BQi2fD1meYppAeKWx4ixDlwGN3hz8EAK_zAjlroA358uk_Zr-vvP69uFsu7H7dXl8uFzUtZLmrXQKsVWle3rZYZ5qrMcyUcZI1wVVU3SlZ11aCUTZsmXCFqK7AqsrxtpKrzU3a279346c-MIZqBgsW-hxGnOZhMFVrVpc526JcX6Hqa_Zi2S5Qqa5lVuU7UxZ6yfgrBY2s2ngbwWyOF2Qk0O0Vmp8v8F5gmPj_1zs2A7sA_G0uA2gOPSc72tT5zeb_cF_8DbIqo6w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2557912836</pqid></control><display><type>article</type><title>Familial aggregation of juvenile idiopathic arthritis with other autoimmune diseases: Impact on clinical characteristics, disease activity status and disease damage</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Al‐Mayouf, Sulaiman M. ; Alrasheedi, Abeer ; Almsellati, Iman ; Hashad, Soad ; Khawaja, Khulood ; Abdwani, Reem ; AlHashim, Samia ; Muzaffer, Mohammed ; Lotfy, Hala ; Almutairi, Nora</creator><creatorcontrib>Al‐Mayouf, Sulaiman M. ; Alrasheedi, Abeer ; Almsellati, Iman ; Hashad, Soad ; Khawaja, Khulood ; Abdwani, Reem ; AlHashim, Samia ; Muzaffer, Mohammed ; Lotfy, Hala ; Almutairi, Nora</creatorcontrib><description>Objectives To evaluate the impact of family history of autoimmune diseases (FHADs) on the clinical characteristics and outcome of juvenile idiopathic arthritis (JIA). Methods We retrospectively reviewed children with JIA seen in 7 pediatric rheumatology clinics from 6 Arab countries. All included patients met the International League of Associations for Rheumatology classification criteria for JIA and had a disease duration greater than 1 year. Data were collected at the last follow‐up visit and comprised clinical findings, including FHADs. Disease activity and disease damage were assessed by Juvenile Arthritis Multidimensional Assessment Report, and juvenile arthritis damage index (JADI) respectively. Disease activity was categorized as remission off treatment, remission on treatment, or active disease. Results A total of 349 (224 females) JIA patients with a disease duration of 5 (interquartile range 2.9‐7.5) years were included. The most frequent JIA categories were polyarticular JIA and oligoarticular JIA, followed by systemic JIA. There were 189 patients with FHADs and 160 patients without FHADs. The most frequent FHADs were diabetes mellitus (21.2%), JIA (18.5%), rheumatoid arthritis (12.7%). Among patients with FHADs, 140/189 (74.1%) achieved clinical remission, while 131/160 (81.9%) patients without FHDs had clinical remission (odds ratio [OR] = 1.2, 95% CI 0.97‐1.5). Rate of consanguinity, enthesitis‐related arthritis (ERA) and psoriatic arthritis were higher in patients with FHADs (OR = 0.6, 95% CI 0.4‐0.9 and OR = 1.2, 95% CI 1.1‐1.4). Also, articular JADI correlated significantly with presence of FHADs (OR = 1.1, 95% CI 1.0‐1.1). Conclusion This study shows that autoimmune diseases cluster within families of patients with JIA with a high proportion of ERA and psoriatic arthritis. JIA patients with FHADs are likely to have more disease damage.</description><identifier>ISSN: 1756-1841</identifier><identifier>EISSN: 1756-185X</identifier><identifier>DOI: 10.1111/1756-185X.14167</identifier><identifier>PMID: 34184820</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Arthritis ; Arthritis, Juvenile - diagnosis ; Arthritis, Juvenile - drug therapy ; Arthritis, Juvenile - genetics ; Arthritis, Juvenile - immunology ; Autoimmune diseases ; Autoimmune Diseases - diagnosis ; Autoimmune Diseases - drug therapy ; Autoimmune Diseases - genetics ; Autoimmune Diseases - immunology ; Autoimmunity - genetics ; Child ; Child, Preschool ; Consanguinity ; Diabetes mellitus ; Disease ; familial arthritis ; familial autoimmune diseases ; Female ; Genetic Predisposition to Disease ; Heredity ; Humans ; juvenile arthritis damage index ; juvenile arthritis disease activity score ; juvenile idiopathic arthritis ; Male ; Middle East ; Patients ; Pediatrics ; Pedigree ; Prognosis ; Psoriatic arthritis ; Remission ; Remission (Medicine) ; Retrospective Studies ; Rheumatoid arthritis ; Rheumatology ; Risk Assessment ; Risk Factors</subject><ispartof>International journal of rheumatic diseases, 2021-08, Vol.24 (8), p.1080-1085</ispartof><rights>2021 Asia Pacific League of Associations for Rheumatology and John Wiley &amp; Sons Australia, Ltd.</rights><rights>International Journal of Rheumatic Diseases © 2021 Asia Pacific League of Associations for Rheumatology and John Wiley &amp; Sons Australia, Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3717-9dbaf65ecd9ff612e3573350da2b0d889b51898be11bf371d409c0e8423fb1593</citedby><cites>FETCH-LOGICAL-c3717-9dbaf65ecd9ff612e3573350da2b0d889b51898be11bf371d409c0e8423fb1593</cites><orcidid>0000-0003-0142-6698</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2F1756-185X.14167$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2F1756-185X.14167$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34184820$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Al‐Mayouf, Sulaiman M.</creatorcontrib><creatorcontrib>Alrasheedi, Abeer</creatorcontrib><creatorcontrib>Almsellati, Iman</creatorcontrib><creatorcontrib>Hashad, Soad</creatorcontrib><creatorcontrib>Khawaja, Khulood</creatorcontrib><creatorcontrib>Abdwani, Reem</creatorcontrib><creatorcontrib>AlHashim, Samia</creatorcontrib><creatorcontrib>Muzaffer, Mohammed</creatorcontrib><creatorcontrib>Lotfy, Hala</creatorcontrib><creatorcontrib>Almutairi, Nora</creatorcontrib><title>Familial aggregation of juvenile idiopathic arthritis with other autoimmune diseases: Impact on clinical characteristics, disease activity status and disease damage</title><title>International journal of rheumatic diseases</title><addtitle>Int J Rheum Dis</addtitle><description>Objectives To evaluate the impact of family history of autoimmune diseases (FHADs) on the clinical characteristics and outcome of juvenile idiopathic arthritis (JIA). Methods We retrospectively reviewed children with JIA seen in 7 pediatric rheumatology clinics from 6 Arab countries. All included patients met the International League of Associations for Rheumatology classification criteria for JIA and had a disease duration greater than 1 year. Data were collected at the last follow‐up visit and comprised clinical findings, including FHADs. Disease activity and disease damage were assessed by Juvenile Arthritis Multidimensional Assessment Report, and juvenile arthritis damage index (JADI) respectively. Disease activity was categorized as remission off treatment, remission on treatment, or active disease. Results A total of 349 (224 females) JIA patients with a disease duration of 5 (interquartile range 2.9‐7.5) years were included. The most frequent JIA categories were polyarticular JIA and oligoarticular JIA, followed by systemic JIA. There were 189 patients with FHADs and 160 patients without FHADs. The most frequent FHADs were diabetes mellitus (21.2%), JIA (18.5%), rheumatoid arthritis (12.7%). Among patients with FHADs, 140/189 (74.1%) achieved clinical remission, while 131/160 (81.9%) patients without FHDs had clinical remission (odds ratio [OR] = 1.2, 95% CI 0.97‐1.5). Rate of consanguinity, enthesitis‐related arthritis (ERA) and psoriatic arthritis were higher in patients with FHADs (OR = 0.6, 95% CI 0.4‐0.9 and OR = 1.2, 95% CI 1.1‐1.4). Also, articular JADI correlated significantly with presence of FHADs (OR = 1.1, 95% CI 1.0‐1.1). Conclusion This study shows that autoimmune diseases cluster within families of patients with JIA with a high proportion of ERA and psoriatic arthritis. JIA patients with FHADs are likely to have more disease damage.</description><subject>Arthritis</subject><subject>Arthritis, Juvenile - diagnosis</subject><subject>Arthritis, Juvenile - drug therapy</subject><subject>Arthritis, Juvenile - genetics</subject><subject>Arthritis, Juvenile - immunology</subject><subject>Autoimmune diseases</subject><subject>Autoimmune Diseases - diagnosis</subject><subject>Autoimmune Diseases - drug therapy</subject><subject>Autoimmune Diseases - genetics</subject><subject>Autoimmune Diseases - immunology</subject><subject>Autoimmunity - genetics</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Consanguinity</subject><subject>Diabetes mellitus</subject><subject>Disease</subject><subject>familial arthritis</subject><subject>familial autoimmune diseases</subject><subject>Female</subject><subject>Genetic Predisposition to Disease</subject><subject>Heredity</subject><subject>Humans</subject><subject>juvenile arthritis damage index</subject><subject>juvenile arthritis disease activity score</subject><subject>juvenile idiopathic arthritis</subject><subject>Male</subject><subject>Middle East</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>Pedigree</subject><subject>Prognosis</subject><subject>Psoriatic arthritis</subject><subject>Remission</subject><subject>Remission (Medicine)</subject><subject>Retrospective Studies</subject><subject>Rheumatoid arthritis</subject><subject>Rheumatology</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><issn>1756-1841</issn><issn>1756-185X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1r3DAQhkVpaNK0596KoJccuolkW7LdWwhNE1hIDi30JsbSeD2LP7aSnLD_pz-02m6yh1yii8SrZ14GHsY-SXEu07mQpdILWanf57KQunzDTg7J28O7kMfsfQhrIbTMdfmOHedFSqtMnLC_1zBQT9BzWK08riDSNPKp5ev5AUfqkZOjaQOxI8vBx85TpMAfKXZ8ih16DnOcaBjmEbmjgBAwfOO3wwZs5KnK9jSSTf22A58y9BQi2fD1meYppAeKWx4ixDlwGN3hz8EAK_zAjlroA358uk_Zr-vvP69uFsu7H7dXl8uFzUtZLmrXQKsVWle3rZYZ5qrMcyUcZI1wVVU3SlZ11aCUTZsmXCFqK7AqsrxtpKrzU3a279346c-MIZqBgsW-hxGnOZhMFVrVpc526JcX6Hqa_Zi2S5Qqa5lVuU7UxZ6yfgrBY2s2ngbwWyOF2Qk0O0Vmp8v8F5gmPj_1zs2A7sA_G0uA2gOPSc72tT5zeb_cF_8DbIqo6w</recordid><startdate>202108</startdate><enddate>202108</enddate><creator>Al‐Mayouf, Sulaiman M.</creator><creator>Alrasheedi, Abeer</creator><creator>Almsellati, Iman</creator><creator>Hashad, Soad</creator><creator>Khawaja, Khulood</creator><creator>Abdwani, Reem</creator><creator>AlHashim, Samia</creator><creator>Muzaffer, Mohammed</creator><creator>Lotfy, Hala</creator><creator>Almutairi, Nora</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0142-6698</orcidid></search><sort><creationdate>202108</creationdate><title>Familial aggregation of juvenile idiopathic arthritis with other autoimmune diseases: Impact on clinical characteristics, disease activity status and disease damage</title><author>Al‐Mayouf, Sulaiman M. ; Alrasheedi, Abeer ; Almsellati, Iman ; Hashad, Soad ; Khawaja, Khulood ; Abdwani, Reem ; AlHashim, Samia ; Muzaffer, Mohammed ; Lotfy, Hala ; Almutairi, Nora</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3717-9dbaf65ecd9ff612e3573350da2b0d889b51898be11bf371d409c0e8423fb1593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Arthritis</topic><topic>Arthritis, Juvenile - diagnosis</topic><topic>Arthritis, Juvenile - drug therapy</topic><topic>Arthritis, Juvenile - genetics</topic><topic>Arthritis, Juvenile - immunology</topic><topic>Autoimmune diseases</topic><topic>Autoimmune Diseases - diagnosis</topic><topic>Autoimmune Diseases - drug therapy</topic><topic>Autoimmune Diseases - genetics</topic><topic>Autoimmune Diseases - immunology</topic><topic>Autoimmunity - genetics</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Consanguinity</topic><topic>Diabetes mellitus</topic><topic>Disease</topic><topic>familial arthritis</topic><topic>familial autoimmune diseases</topic><topic>Female</topic><topic>Genetic Predisposition to Disease</topic><topic>Heredity</topic><topic>Humans</topic><topic>juvenile arthritis damage index</topic><topic>juvenile arthritis disease activity score</topic><topic>juvenile idiopathic arthritis</topic><topic>Male</topic><topic>Middle East</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>Pedigree</topic><topic>Prognosis</topic><topic>Psoriatic arthritis</topic><topic>Remission</topic><topic>Remission (Medicine)</topic><topic>Retrospective Studies</topic><topic>Rheumatoid arthritis</topic><topic>Rheumatology</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Al‐Mayouf, Sulaiman M.</creatorcontrib><creatorcontrib>Alrasheedi, Abeer</creatorcontrib><creatorcontrib>Almsellati, Iman</creatorcontrib><creatorcontrib>Hashad, Soad</creatorcontrib><creatorcontrib>Khawaja, Khulood</creatorcontrib><creatorcontrib>Abdwani, Reem</creatorcontrib><creatorcontrib>AlHashim, Samia</creatorcontrib><creatorcontrib>Muzaffer, Mohammed</creatorcontrib><creatorcontrib>Lotfy, Hala</creatorcontrib><creatorcontrib>Almutairi, Nora</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Al‐Mayouf, Sulaiman M.</au><au>Alrasheedi, Abeer</au><au>Almsellati, Iman</au><au>Hashad, Soad</au><au>Khawaja, Khulood</au><au>Abdwani, Reem</au><au>AlHashim, Samia</au><au>Muzaffer, Mohammed</au><au>Lotfy, Hala</au><au>Almutairi, Nora</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Familial aggregation of juvenile idiopathic arthritis with other autoimmune diseases: Impact on clinical characteristics, disease activity status and disease damage</atitle><jtitle>International journal of rheumatic diseases</jtitle><addtitle>Int J Rheum Dis</addtitle><date>2021-08</date><risdate>2021</risdate><volume>24</volume><issue>8</issue><spage>1080</spage><epage>1085</epage><pages>1080-1085</pages><issn>1756-1841</issn><eissn>1756-185X</eissn><abstract>Objectives To evaluate the impact of family history of autoimmune diseases (FHADs) on the clinical characteristics and outcome of juvenile idiopathic arthritis (JIA). Methods We retrospectively reviewed children with JIA seen in 7 pediatric rheumatology clinics from 6 Arab countries. All included patients met the International League of Associations for Rheumatology classification criteria for JIA and had a disease duration greater than 1 year. Data were collected at the last follow‐up visit and comprised clinical findings, including FHADs. Disease activity and disease damage were assessed by Juvenile Arthritis Multidimensional Assessment Report, and juvenile arthritis damage index (JADI) respectively. Disease activity was categorized as remission off treatment, remission on treatment, or active disease. Results A total of 349 (224 females) JIA patients with a disease duration of 5 (interquartile range 2.9‐7.5) years were included. The most frequent JIA categories were polyarticular JIA and oligoarticular JIA, followed by systemic JIA. There were 189 patients with FHADs and 160 patients without FHADs. The most frequent FHADs were diabetes mellitus (21.2%), JIA (18.5%), rheumatoid arthritis (12.7%). Among patients with FHADs, 140/189 (74.1%) achieved clinical remission, while 131/160 (81.9%) patients without FHDs had clinical remission (odds ratio [OR] = 1.2, 95% CI 0.97‐1.5). Rate of consanguinity, enthesitis‐related arthritis (ERA) and psoriatic arthritis were higher in patients with FHADs (OR = 0.6, 95% CI 0.4‐0.9 and OR = 1.2, 95% CI 1.1‐1.4). Also, articular JADI correlated significantly with presence of FHADs (OR = 1.1, 95% CI 1.0‐1.1). Conclusion This study shows that autoimmune diseases cluster within families of patients with JIA with a high proportion of ERA and psoriatic arthritis. JIA patients with FHADs are likely to have more disease damage.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>34184820</pmid><doi>10.1111/1756-185X.14167</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-0142-6698</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1756-1841
ispartof International journal of rheumatic diseases, 2021-08, Vol.24 (8), p.1080-1085
issn 1756-1841
1756-185X
language eng
recordid cdi_proquest_miscellaneous_2546597629
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Arthritis
Arthritis, Juvenile - diagnosis
Arthritis, Juvenile - drug therapy
Arthritis, Juvenile - genetics
Arthritis, Juvenile - immunology
Autoimmune diseases
Autoimmune Diseases - diagnosis
Autoimmune Diseases - drug therapy
Autoimmune Diseases - genetics
Autoimmune Diseases - immunology
Autoimmunity - genetics
Child
Child, Preschool
Consanguinity
Diabetes mellitus
Disease
familial arthritis
familial autoimmune diseases
Female
Genetic Predisposition to Disease
Heredity
Humans
juvenile arthritis damage index
juvenile arthritis disease activity score
juvenile idiopathic arthritis
Male
Middle East
Patients
Pediatrics
Pedigree
Prognosis
Psoriatic arthritis
Remission
Remission (Medicine)
Retrospective Studies
Rheumatoid arthritis
Rheumatology
Risk Assessment
Risk Factors
title Familial aggregation of juvenile idiopathic arthritis with other autoimmune diseases: Impact on clinical characteristics, disease activity status and disease damage
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T00%3A12%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Familial%20aggregation%20of%20juvenile%20idiopathic%20arthritis%20with%20other%20autoimmune%20diseases:%20Impact%20on%20clinical%20characteristics,%20disease%20activity%20status%20and%20disease%20damage&rft.jtitle=International%20journal%20of%20rheumatic%20diseases&rft.au=Al%E2%80%90Mayouf,%20Sulaiman%20M.&rft.date=2021-08&rft.volume=24&rft.issue=8&rft.spage=1080&rft.epage=1085&rft.pages=1080-1085&rft.issn=1756-1841&rft.eissn=1756-185X&rft_id=info:doi/10.1111/1756-185X.14167&rft_dat=%3Cproquest_cross%3E2546597629%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2557912836&rft_id=info:pmid/34184820&rfr_iscdi=true